All systems operational
Q3 2025

Corrigendum to: UAE Consensus on Patient Profiles for Pre-exposure Prophylaxis with Monoclonal Antibodies against COVID-19 in Hematological Malignancies and Immunocompromised States

Shahrukh Hashmi · Jehad Abdalla · Arif Raza Alam · Mohamed Abuhaleeqa · Amna Al Mehiri · Biju George · Amar Lal · Hani Yousif Osman · Panayotis Kaloyannidis
10.2174/025068820501250516143704 387 Views 0 Citations
0
Citations
387
Views
Abstract



The authors requested to update the acknowledgement,
funding, and authors contribution section in their article titled
“UAE Consensus on Patient Profiles for Pre-exposure
Prophylaxis with Monoclonal Antibodies against COVID-19 in
Hematological Malignancies and Immunocompromised States”
published in “New Emirates Medical Journal,” 2024; 5:
e02506882347591 [1].

We apologize for any inconvenience caused and
appreciate the opportunity to rectify this matter.

The original article can be found online at https://www.
eurekaselect.com/article/147185

Original:

AUTHORS’ CONTRIBUTIONS

It is hereby acknowledged that all authors have accepted
responsibility for the manuscript's content and consented to its
submission. They have meticulously reviewed all results and
unanimously approved the final version of the manuscript.

FUNDING

None.

ACKNOWLEDGEMENTS

Declared none.

Corrected:

AUTHORS’ CONTRIBUTIONS

S.H., J.A., A.R.A., M.A., A.Al.M., B.G., A.L., H.Y.O.,
P.K.: All contributed to the delphie and discus-sion meetings;
S.H., A.Al.M., A.R.A. and M.A.: Contributed to writing the
main manuscript; S.H., B.G., A.L., H.Y.O., P.K.: Contributed
to revising the main manuscript.

FUNDING

The consensus logistics and medical publication was
funded by AstraZeneca FZ LLC, Dubai, United Arab Emirates.

ACKNOWLEDGEMENTS

The authors extend their sincere gratitude to Meeting
Minds Medical Communications Agency for their unwavering
support in medical content development, including invaluable
editorial and formatting assis-tance, which significantly
contributed to the successful completion of the manuscript.
Additionally, we express our appreciation to the Emirates
Society of Hematology (ESH) for their endorsement of this
work, further enhancing its credibility and relevance within the
field. A courtesy copy of the final manuscript was provided to
AstraZeneca as a gesture of acknowledgment for their interest
in this research endeavor.

Cite this Article (APA)
Shahrukh, H., Jehad, A., Arif, R. A., Mohamed, A., Amna, A. M., Biju, G., Amar, L., Hani, Y. O., Panayotis, K. (2025). Corrigendum to: UAE Consensus on Patient Profiles for Pre-exposure Prophylaxis with Monoclonal Antibodies against COVID-19 in Hematological Malignancies and Immunocompromised States. New Emirates Medical Journal. https://doi.org/10.2174/025068820501250516143704
Related Papers
Anabolic Androgenic Steroids: A Review
Siya Rohilla; Prerna Sharma; Sweta Kamboj; Sanchit Dhankhar; Nitika Garg; Samrat · 2024
11
cites
386
Caveolae’s Behavior in Norm and Pathology
Basheer Abdullah Marzoog · 2023
10
cites
389
A Comprehensive Review of Alternative Therapeutic Approaches for Nausea and Vomiting Relief in Pregn…
Manish Panchal; Priyakshi Rana; Nitika Garg; Sanchit Dhankhar; Himanshu Sharma; · 2024
10
cites
385
Prevalence and Impact of Dysmenorrhea on the Academic Performance of Students at Medical and Health …
Nayesha Mahwish; Rajani Dube; Subhranshu Sekhar Kar; Malavika Santhosh; Alweena · 2024
8
cites
389
Access
View Full Text via DOI
Published in
ISSN 0250-6882
Quartile Q3
AMS Score 57
Field Medicine & Health Sciences
Publisher Bentham Science Publishers Ltd.
Country 🇦🇪 UAE
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 30 Jul 2026